Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease-Reference-Cited by-同舟云学术

Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease

Published:2014-07-10 Issue:2 Volume:21 Page:195-210
ISSN:1523-0864
Container-title:Antioxidants & Redox Signaling
language:en
Short-container-title:Antioxidants & Redox Signaling

Author:

Devos David¹²³,Moreau Caroline²³,Devedjian Jean Christophe³⁴,Kluza Jérome⁵,Petrault Maud¹³,Laloux Charlotte¹³,Jonneaux Aurélie¹³,Ryckewaert Gilles²³,Garçon Guillaume⁶,Rouaix Nathalie⁷,Duhamel Alain⁸,Jissendi Patrice⁹,Dujardin Kathy²³,Auger Florent³¹⁰,Ravasi Laura³¹¹,Hopes Lucie²,Grolez Guillaume²,Firdaus Wance¹³,Sablonnière Bernard⁷,Strubi-Vuillaume Isabelle⁷,Zahr Noel¹²,Destée Alain²¹³,Corvol Jean-Christophe¹⁴,Pöltl Dominik¹⁵¹⁶,Leist Marcel¹⁵¹⁶,Rose Christian¹⁷,Defebvre Luc²³,Marchetti Philippe⁵,Cabantchik Z. Ioav¹⁸,Bordet Régis¹³

Affiliation:

1. Department of Medical Pharmacology, Faculté de Médecine Lille2, Lille Nord de France University, CHU Lille, Lille, France.

2. Department of Movement Disorders and Neurology, Lille Nord de France University, CHU Lille, Lille, France.

3. EA 1046, Lille Nord de France University, Lille, France.

4. University of the Littoral, Lille Nord de France University, Lille, France.

5. Unit 837 Equipe 4 Inserm and Faculté de Médecine, Lille Nord de France University, Lille, France.

6. Department of Toxicology, Public Health and Environment, EA4483, Faculté des Sciences Pharmaceutiques et Biologiques de Lille, Lille, France.

7. Department of Molecular Biology, Lille Nord de France University, CHU Lille, Lille, France.

8. Department of Biostatistics, Lille Nord de France University, CHU Lille, Lille, France.

9. Department Neuroradiology, Lille Nord de France University, CHU Lille, Lille, France.

10. Department of Animal Neuroradiology, Lille Nord de France University, Lille, France.

11. Department of Animal Nuclear Medicine, Lille Nord de France University, Lille, France.

12. Department of Pharmacology, APHP, Pitié-Salpêtrière Hospital, Paris, France.

13. INSERM U837/6 JPARC Université Lille Nord de France, Lille, France.

14. INSERM, CR-ICM, UMRS975, CNRS UMR7225, UPMC, INSERM, CIC-9503, Department of Neurology, Pitié-Salpêtrière Hospital, Paris, France.

15. Doerenkamp-Zbinden Chair for In Vitro Toxicology and Biomedicine, University of Konstanz, Konstanz, Germany.

16. Konstanz Research School Chemical Biology, University of Konstanz, Konstanz, Germany.

17. Department of Hematology, Hôpital Saint Vincent de Paul, Lille Nord de France University, Lille, France.

18. Della Pergola Chair, Alexander Silberman Institute of Life Sciences, Hebrew University, Jerusalem, Israel.

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Clinical Biochemistry,Molecular Biology,Physiology,Biochemistry,Cell Biology,Clinical Biochemistry,Molecular Biology,Physiology,Biochemistry

Link

http://www.liebertpub.com/doi/pdf/10.1089/ars.2013.5593

Reference74 articles.

1. A pilot trial of deferiprone for neurodegeneration with brain iron accumulation

2. Selective iron chelation in Friedreich ataxia: biologic and clinical implications

3. The Mitochondrial Dynamics of Alzheimers Disease and Parkinsons Disease Offer Important Opportunities for Therapeutic Intervention

4. Intracellular labile iron

5. Modulation of Somatodendritic Dopamine Release by Endogenous H2O2: Susceptibility in Substantia Nigra But Resistance in VTA

Cited by 491 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ferroptosis in Parkinson's disease —— The iron-related degenerative disease;Ageing Research Reviews;2024-11

2. Neuroprotective effects of intranasal extracellular vesicles from human platelet concentrates supernatants in traumatic brain injury and Parkinson’s disease models;Journal of Biomedical Science;2024-09-05

3. Deferiprone promoted remyelination and functional recovery through enhancement of oligodendrogenesis in experimental demyelination animal model;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-07-24

4. Bidirectional two-sample Mendelian randomization analysis identifies causal associations between oxidative stress and Parkinson’s disease;Frontiers in Aging Neuroscience;2024-07-04

5. Targeting ferroptosis in neuroimmune and neurodegenerative disorders for the development of novel therapeutics;Biomedicine & Pharmacotherapy;2024-07